%0 Journal Article
%T Once-Daily MMX Mesalamine in the Management of Ulcerative Colitis
%A Wojciech Blonski
%A Anna M. Buchner and Gary R. Lichtenstein
%J Clinical Medicine Insights: Gastroenterology
%D 2012
%I 
%R 10.4137/CGast.S4276
%X Mesalamine (5-ASA) has been the mainstay therapy of mild to moderate active ulcerative colitis both as an induction and maintenance treatment. Multimatrix system (MMX) 5-ASA is a recently developed formulation of 5-ASA allowing for slow and gradual release of 5-ASA throughout the entire colon. This review article discusses the structure, pharmacokinetics, efficacy and safety of this new 5-ASA formulation.
%U http://www.la-press.com/once-daily-mmx-mesalamine-in-the-management-of-ulcerative-colitis-article-a2672